MedPath
NMPA Approval

Bortezomib for Injection

国药准字H20234717

December 29, 2023

Drug Information

注射用硼替佐米

注射剂

3.5mg

化学药品

December 29, 2023

Company Information

Applicant Company

深圳市坪山新区兰竹东路国家生物医药产业基地万乐药业大厦

Manufacturing Company

深圳国家生物医药产业基地坪山新区兰竹东路万乐药业大厦

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用硼替佐米 - NMPA 批准文号 | MedPath